Overview
Novotech is the leading Asia-Pacific biotech specialist CRO with global execution capabilities. Novotech is a clinical CRO with labs, phase I facilities, and drug development consulting services. It has accumulated experience in over 3,700 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. Novotech is positioned to serve biopharmaceutical clients conducting clinical trials in Asia, the US and globally. With the acquisition of a US based CRO in May 2022, Novotech has over 2500 staff working across our offices in 13 geographies.
NOVOTECH IS INTERNATIONALLY RECOGNIZED AS THE LEADING ASIA PACIFIC CONTRACT RESEARCH ORGANIZATION WITH GLOBAL EXECUTION CAPABILITIES (CRO).